Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) announces preliminary preclinical data of TATX-03 PolyTope antibody cocktail program against SARS-CoV-2, the virus that causes COVID-19 disease.
- In the SARS-CoV-2 hamster model, treatment with TATX-03 resulted in complete clearance of detectable replication-competent virus from the lungs and throat of SARS-CoV-2 infected animals by day four post-infection.
- Furthermore, the study showed undetectable virus titer levels in the throat of 100% of the infected hamsters three days after virus infection.
- The results also demonstrated the TATX-03 antibody cocktail's potential to provide anti-viral effects against SARS-CoV-2 in both prophylactic (preventative) and treatment settings.
- The company said that 27 neutralizing lead candidate antibodies would be analyzed to generate full interaction profiles against seventeen different SARS-CoV-2 variants. Data is expected by early next month.
- IPA plans to start the final IND-enabling studies in late Q2 2021.
- Price Action: IPA increased 5.37% at $16.30 in market trading hours on last check Friday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!